CRISPR screening identifies the deubiquitylase ATXN3 as a PD-L1–positive regulator for tumor immune evasion-Reference-Cited by-全球学者库

登录注册会员服务联系我们

CRISPR screening identifies the deubiquitylase ATXN3 as a PD-L1–positive regulator for tumor immune evasion

Published:2023-12-01 Issue:23 Volume:133 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Wang Shengnan,Iyer Radhika^ORCID,Han Xiaohua,Wei Juncheng,Li Na,Cheng Yang,Zhou Yuanzhang,Gao Qiong,Zhang Lingqiang,Yan Ming^ORCID,Sun Zhaolin,Fang Deyu^ORCID

Funder

NIH

National Natural Science Foundation of China

Shandong Province Natural Science Foundation

Dalian High-level Talent Innovation Support Program

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/167728/files/pdf

Reference63 articles.

1. Cancer immunotherapy using checkpoint blockade

2. A decade of immune-checkpoint inhibitors in cancer therapy

3. Negative Regulation of T-Cell Function by PD-1

4. MYC regulates the antitumor immune response through CD47 and PD-L1

5. Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1)

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前全球学者库共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP